Dergiler / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 5

Interlukine-17 and TGF-ß levels in patients with acute brucellosisbefore and after treatment

Sayfa
1348–1352
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: This study indicated that TGF-β was lower and IL-17 was higher in brucellosis cases and, after treatment, the serum level of TGF-β increased and that of IL-17 decreased in these patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: T-helper cell type 1 (Th1)/Th2 cytokine balance is involved in the resistance or susceptibility to Brucella infection.
📊
Temel Bulgular & Veri:The aim of this study was to investigate the levels of serum interleukin-17 (IL-17) and transforming growth factor beta (TGF-β) and their alterations with treatment in patients with acute brucellosis.
💡
Sonuç & Katkı:Conclusion: This study indicated that TGF-β was lower and IL-17 was higher in brucellosis cases and, after treatment, the serum level of TGF-β increased and that of IL-17 decreased in these patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: T-helper cell type 1 (Th1)/Th2 cytokine balance is involved in the resistance or susceptibility to Brucella infection. The analysis of cytokine levels is valuable to determine the role of the immune system in Brucella prognosis. The aim of this study was to investigate the levels of serum interleukin-17 (IL-17) and transforming growth factor beta (TGF-β) and their alterations with treatment in patients with acute brucellosis. Materials and methods: TGF-β was tested in 33 acute brucellosis patients and 19 controls and IL-17 was analyzed in 40 patients and 12 controls. Cytokine levels were tested in controls and patients before and after treatment by ELISA. Results: TGF-β levels were significantly lower in brucellosis cases compared to controls. At the end of the treatment, the serum levels of this cytokine had increased, but there was no significant difference between this cytokine level before and after treatment. The IL-17 level was significantly higher in the brucellosis group compared to controls and its value decreased in patients at the end of treatment without any significant difference. Conclusion: This study indicated that TGF-β was lower and IL-17 was higher in brucellosis cases and, after treatment, the serum level of TGF-β increased and that of IL-17 decreased in these patients.

🔖

Bu Makaleye Atıf Yap

CHEREI, S., SOFIAN, M., MOUSAVI, A., BANIFAZL, M., CHEREI, A., AGHAKHANI, A., RAMEZANI, A. (2022). Interlukine-17 and TGF-ß levels in patients with acute brucellosisbefore and after treatment. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 5, 1348–1352. https://ajindex.com/articles/610643

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Karaoglan I, Pehlivan S, Namiduru M, Pehlivan M, Kilinçarslan C, Balkan Y, Baydar I. TNF-α, TGF-β, IL10, IL-6 and IFN-γ gene polymorphisms as risk factors for brucellosis. New Microbiol 2009; 32: 173-178
  2. Eskandari-Nasab E, Moghadampour M, Hasani SS, HadadiFishani M, Mirghanizadeh-Bafghi SA, Asadi-Saghandi A, Zare F, Sadeghi-Kalani B, Ghazali-Bina M. Relationship between γ-interferon gene polymorphisms and susceptibility to brucellosis infection. Microbiol Immunol 2013; 57: 785-791
  3. Baldi PC, Giambartolomei GH. Immunopathology of Brucella infection. Recent Pat Antiinfect Drug Discov 2013; 8: 18-26
  4. Pappas G, Memish ZA. Brucellosis in the Middle East: a persistent medical, socioeconomic and political issue. J Chemother 2007; 19: 243-248
  5. Ahmed K, Al-Matrouk KA, Martinez G, Oishi K, Rotimi VO, Nagatake T. Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. Am J Trop Med Hyg 1999; 61: 425-427
  6. Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: a case– control study. Int J Infect Dis 2008; 12: 157-161
  7. Von Bargen K, Gorvel JP, Salcedo SP. Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev 2012; 36: 533-562
  8. Farahani SH, Shah Mohamadi S, Navidi I, Sofian M. An investigation of the epidemiology of brucellosis in Arak City, Iran, (2001-2010). Arak Med University J 2012; 14: 49-54 (in Persian)
  9. Sofian M, Aghakhani A, Banifazl M, Eslamifar A, Zolfaghari F, Sarmadian H, Ramezani A. Differentiation of Brucella-induced epididymo-orchitis from nonspecific epididymo-orchitis in an endemic area for brucellosis. J Med Microbiol Infec Dis 2013, 1: 8-13
  10. Rasouli M, Asaei S, Kalani M, Kiany S, Moravej A. Interleukin17A genetic variants can confer resistance to brucellosis in Iranian population. Cytokine 2013; 61: 297-303
  11. Orozco G, Sánchez E, López-Nevot MA, Caballero A, Bravo MJ, Morata P, de Dios Colmenero J, Alonso A, Martín J. Inducible nitric oxide synthase promoter polymorphism in human brucellosis. Microbes Infect 2003; 5: 1165-1169
  12. Eskandari-Nasab E, Moghadampour M, Asadi-Saghandi A, Kharazi-Nejad E, Rezaeifar A, Pourmasoumi H. Levels of interleukin-(IL)-12p40 are markedly increased in brucellosis among patients with specific IL-12B genotypes. Scand J Immunol 2013; 78: 85-91
  13. Oñate A, Andrews E, Beltran A, Eller G, Schurig G, Folch H. Frequent exposure of mice to crude Brucella abortus